Delivery Order SPE2DB22D2005-SPE2DB25FJRL5
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $34,811.78 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on August 29, 2025, with completion scheduled for September 2, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The vaccine delivery will be performed at AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,345.16 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on August 6, 2025, with an ultimate completion date of August 7, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, serves as...
- The Defense Logistics Agency awarded a delivery order contract valued at $18,016.80 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on August 5, 2025, with an ultimate completion date of August 6, 2025. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,462.82 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on July 18, 2025, with an ultimate completion date of July 21, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $47,038.50 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on August 14, 2025, with completion scheduled for August 15, 2025. This firm fixed-price contract represents a competitively awarded, non-set-aside procurement supporting federal medical supply requirements. The award was issued to AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, the company's headquarters and primary distribution hub for...
- The Defense Logistics Agency awarded a delivery order valued at $35,901.99 to AmerisourceBergen Drug Corp for MMR II vaccine vials on September 16, 2025, with an ultimate completion date of September 17, 2025. The contract employs firm fixed-price pricing and was awarded competitively without a set-aside designation. Performance will take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract action under the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,925.33 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on September 11, 2025. This is a firm fixed price delivery order with an ultimate completion date of September 12, 2025, and represents performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation, consistent with AmerisourceBergen's standard federal procurement...
- The Defense Logistics Agency awarded a $1,484.82 firm fixed price delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on June 2, 2025, with an ultimate completion date of June 3, 2025. The contract, which is a child order under a larger vehicle, was performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania, and was awarded without a set-aside designation through open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $4,511.07 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of July 23, 2025. This firm fixed price contract, issued on July 22, 2025, represents a non-competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, where the company serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $33,522.33 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with completion scheduled for September 2, 2025. The award, issued on August 29, 2025, represents a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJRL5Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $19,858.32 to AmerisourceBergen Drug Corp for MMR II vaccine vials on August 13, 2025, with an ultimate completion date of August 14, 2025. This firm fixed-price contract is a non-set-aside award executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The vaccine delivery will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. As the prime contractor under the DLA Troop Support Medical IDC, the company supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This vaccine delivery order represents one of numerous competitively awarded transactions executed under the broader prime vendor contract vehicle, which enables AmerisourceBergen to serve federal customers including the Defense Health Agency and U.S. Coast Guard across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.9k | 8/13/25 |